6th Congress of International Advanced HBP Surgery (ISLS 2025)
In-Person Event
Oct 22 - 25, 2025
Toronto, Ontario, CA
OVERVIEW
6th Congress of International Advanced HBP Surgery (ISLS 2025) is organized by MCI Canada and will be held from Oct 22 - 25, 2025 at Sheraton Centre Toronto Hotel, Toronto, Ontario, Canada.
Description:
This will be the first ISLS congress in North America. Organized by the International Society of Liver Surgeons (ISLS), this prestigious event will bring together leading experts in hepatobiliary and pancreatic (HBP) surgery from around the world. The congress will feature a comprehensive scientific program, including invited lectures, oral and poster presentations, live demonstrations, and a variety of sessions showcasing the latest advancements in HBP surgery.
In addition to the scientific program, the congress provides numerous networking opportunities, enabling you to connect with peers, exchange knowledge, and discuss current trends and challenges in HBP surgery. Specialized workshops and symposia will highlight cutting-edge surgical techniques and innovations, providing valuable insights and hands-on learning experiences.
An exhibition area will showcase the latest medical devices, technologies, and pharmaceuticals related to HBP surgery, offering participants a chance to explore groundbreaking innovations in the field.
For your convenience, the Sheraton Centre Toronto Hotel, located in the heart of Toronto near the iconic Nathan Phillips Square, offers a variety of accommodation options and nearby activities, with special rates available for congress participants.
We look forward to welcoming you to Toronto, a vibrant and exciting city, for what promises to be an inspiring and enriching conference. Save the date and I will see you in Toronto.
Preliminary Topics:
- Minimally Invasive Surgery / Hepatobiliary Course
- Hepatocellular Carcinoma Day
- Cholangiocarcinoma and Pancreas Day
- Colorectal Cancer Liver Metastases Day
Preliminary Program:
| Day 1: Wednesday, October 22, 2025 |
| WELCOME: Myron Schwartz, Gonzalo Sapisochin |
| SESSION 1: General Principles |
| Moderator: Majella Doyle, Ki-Hun Kim • Bleeding control in minimally invasive liver surgery - Fernando Rotellar • Concept of the Caudal View in MIS Liver Surgery – Where are the limits - Olivier Scatton • Intraglissionian vs. Extraglissionian approach of the pedicle, when and why - Concepcion Gomez Gavarra |
| SESSION 2: How I Do It – General Principles |
| Moderators: Marieke De Boer, Henrik Petrowsky • How to do a safe right and left laparoscopic hepatectomy - Claire Goumard • How to do a safe right and left robotic hepatectomy - Fabrizio Di Benedetto • Extended MIS liver resections including vascular and bile duct resections - Hugo Pinto • MIS liver resections in patients with portal hypertension - Albert Chan |
| SESSION 3: Liver Transplantation |
| Moderators: Deniz Balci, Gonzalo Sapisochin • MIS living donor hepatectomy – Is this standard of care? - Yee Lee Cheah • MIS lap donor surgery - Ki-Hun Kim • Implanting Livers with Robotic Techniques – will this ever take off? - Dieter Broering • Implanting Livers with Laparosocpic Techniques – will this ever take off? - Gyu-Seong Choi |
| SESSION 4: How I do it session - Pancreas |
| Moderator: Sean Cleary • How to do a safe MIS distal pancreatectomy with ad without spleen preservation • How to do a safe MIS Whipple procedure • MIS pancreas resections including vascular resection; DEBATE, Laparoscopic vs. Robotic - Ki Byung Song |
| ISLS OPENING: Welcome remarks Chair: Gonzalo Sapisochin |
| Keynote: LT for HCC - Where are we in 2025? And what the future holds. Speaker: Karim Halazun Q&A Session |
| Day 2: Thursday, October 23, 2025 |
| SESSION 5: Innovations in Hepatocellular Carcinoma Care: Advanced imaging techniques, AI and the future of liver directed imaging |
| Moderator: Karim Halazun, Parissa Tabrizian • Liver Navigation and use of ICG in HCC liver surgery - Eric Vibert • AI to diagnose and stage HCC on imaging – Are we there yet? • Advanced liver surgery for HCC with the use of intraoperative navigation techniques - Jiri Fronek • Predicting outcomes of HCC resection and transplant using AI - Guido Torzilli |
| SESSION 6: Tumor Board Presentations |
| Moderators: Prashant Bhangui, Taizo Hibi • Case 1: Resectable HCC in Child B cirrhosis (East vs West experience) - Andrea Ruzzenente & Alfred Kow • Case 2: Advanced HCC with vascular involvement successfully down-staged to resection with Immuno/IR/SBRT (Neoadjuvant) - Sang-Hoon KIM • Case 3: Advanced HCC Neoadjuvant Immuno to Tx - Parissa Tabrizian • Panel: Krishna Menon, Silvio Nadalin, Erica Tsang |
| SESSION 7: Liver Regeneration |
| Moderator: Deniz Balci, Roberto Alejandro Hernandez • Liver Regeneration and Hepatectomy: Where are we in 2025 - Shintaro Yagi • Two-Stage Hepatectomy and Modulation of Future Liver Remnant: Status Quo 2025 - Henrik Petrowsky • Two-Stage Liver Transplantation: APOLT, RAPID update: Status Quo 2025 - Umberto Cillio |
| SESSION 8: Intermediate Stage HCC: Resection vs. Transplantation |
| Moderator: Albert Chan • Surgical Strategies: Resection as a Viable DS strategy in giant and multifocal HCC (Intermediate Stage) - Dong-Sik Kim • The Transplantation Paradigm: Where do we draw the line? Expanding Role and Considerations - Christian Toso • Optimizing Treatment Pathways: Neoadjuvant Approaches in Intermediate Stage HCC: upfront vs LRT vs systemic vs combo approaches - Should u do systemic as neoadjuvant and then surgery - Umut Deirci |
| SESSION 9: Macrovascular Invasion : Balancing Systemic and Curative Options & Biomarkers, Liquid Biopsy: Guiding Precision Medicine in HCC |
| Moderator: Shintaro Yagi • Curative Approaches > Surgery and Locoregional Therapies in the Era of Macrovascular Invasion - Transplant - Prashant Bhangui > Surgery and Locoregional Therapies in the Era of Macrovascular Invasion - Surgery - Shimul Shah > Surgery and Locoregional Therapies in the Era of Macrovascular Invasion - IR - Robert Lewandowski > Surgery and Locoregional Therapies in the Era of Macrovascular Invasion - SBRT - Laura Dawson • Alpha-fetoprotein and Beyond: Biomarkers in HCC Diagnosis and Prognosis - Augusto Villanueva • Predicting Treatment Response: Biomarker Signatures in Surgery, Immunotherapy and Beyond - Krishna Menon |
| Day 3: Friday, October 24, 2025 |
| SESSION 10: Intrahepatic Cholangiocarcinoma |
| • Resection for locally advanced iCCA, including vascular resections and ALPP - Silvio Nadalin • How effective can be a downstaging therapy? • Incorporating genomic and directed therapies into the management of intrahepatic cholangiocarcinoma - Robert Grant |
| SESSION 11: Hilar Cholangiocarcinoma |
| Moderator: Olivier Scatton • Vascular Resections and Value of Lymphadenectomies in hCCA - Alejandro Serrablo • Optimization of Future Liver Remnant in patients with hCCA - Huake Luong • Liver Transplantation for hCCA - Nicolas Goldaracen • Discussion |
| State of the Art Lecture: Incorporating Genomics in the Management of Resectable and Borderline Resectable Pancreatic Cancer |
| SESSION 12: Controversies in the Management of Pancreatic Cancer |
| Moderator: Orlando Torres • Biological vs technical resectability • Therapeutic approach for borderline tumors • Surgical resection: How far is too far • In the era of robotic surgery: Is laparoscopic Whipple dead? - David Kooby |
| SESSION 13: Pancreas Cancer Tumor Boards |
| • Neoadjuvant Therapy for Resectable Pancreas Cancer PRO • Neoadjuvant Therapy for Resectable Pancreas Cancer CON • Rebuttal Speaker PRO • Rebuttal Speaker CON |
| Day 4: Saturday, October 25, 2025 |
| SESSION 14: Management of Initially Unresectable Liver Metastases |
| • Role of systemic chemotherapy - Erica Tsang • Role of molecular profile and ctDNA • Role of locoregional treatments including Hepatic Artery Infusion Pump (HAIP) - Paul Karanicolas • Role of surgical resection including management of missing metastases - Lucas McCormack • Role of liver transplantation - Roberto Alejandro Hernandez |
| SESSION 15: Opening: DEI in Transplantation Conference |
| • Saturday, October 25 – Sunday, October 26, 2025 Welcome and Intro: Nazia Selzner, Cythina Tsien, Gonzalo Sapisochin |
| Joint ISLS & DEI in Transplant Session • Enabling Exemplary Care Through Behavioural Empathy - Nouman Ashraf |
KEY DATES
TARGET AUDIENCE
StudentsTransplant SurgeonsAllied Health ProfessionalsTraineesSPECIALITIES
Transplant SurgeryCONFERENCE SUMMARY
The 6th Congress of International Advanced HBP Surgery is set to take place in 2025, bringing together leading experts in hepatobiliary and pancreatic surgery. This premier medical conference will feature cutting-edge research, innovative surgical techniques, and interactive workshops. Attendees will have the opportunity to network with top professionals in the field, share insights, and discuss the latest advancements in HBP surgery. With a focus on improving patient outcomes, this event is a must-attend for surgeons, researchers, and healthcare professionals dedicated to advancing surgical practices. Don’t miss your chance to be part of this transformative experience!
SUGGESTED HOTELS
CONFERENCE VENUE
Sheraton Centre Toronto HotelCANCELLATION & REFUND POLICY
Registration Modification and Cancellation:
For cancellations received prior to Tuesday, September 30, 2025, midnight EST, deposits will be refunded minus a 25% administrative charge. After this date, no refunds will be possible.
A name change will be considered as a modification and will be charged 25 USD.
A handling fee of 25 USD per registration will be charged for every registration modification received, including a name change.
